Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 11:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1033–1056 of 1,489 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Suicide, Suicide, Attempted
Interventions: Caring Letter (email); Behavioral
Lead sponsor: National Center for Telehealth and Technology; Federal
Eligibility: 18 Years and older
Enrollment: 1,319 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 5
States / cities: Palo Alto, California • San Diego, California • Honolulu, Hawaii + 2 more

Conditions: Infection
Interventions: Grapefruit Juice; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 2 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Uterine Cervical Neoplasms
Interventions: Zoledronic acid; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Acute Kidney Injury
Interventions: Iopamidol 300 (Contrast), Placebo (Normal Saline); Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Keratitis Bacterial
Interventions: Moxifloxacin Ophthalmic, Difluprednate Ophthalmic, Riboflavin Ophthalmic, Topical Placebo; Drug · Other
Lead sponsor: Thomas M. Lietman; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 2
States / cities: San Francisco, California • Miami, Florida

Conditions: Gastroesophageal Reflux Disease (GERD), Eosinophilic Esophagitis (EoE), Functional Dyspepsia
Interventions: Standard of Care esophagogastroduodenoscopy (EGD) with measurement of mucosal impedance; Diagnostic Test
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 1 Year to 18 Years
Enrollment: 127 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Acute Lymphoblastic Leukemia, Pediatric, Pediatric Cancer
Interventions: Active Music Engagement, Audio Storybooks; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 3 Years to 8 Years
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 4
States / cities: Oakland, California • Chicago, Illinois • Indianapolis, Indiana + 1 more

Conditions: HIV
Interventions: STEP-UP, Philadelphia TelePrEP Program Direct-to-Consumer Model; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 16 Years and older
Enrollment: 92 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Primary Care Appointment Keeping
Interventions: Enhanced contact plus behavioral skills, Enhanced contact only, Standard of Care; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older
Enrollment: 1,838 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 6
States / cities: Birmingham, Alabama • Miami, Florida • Baltimore, Maryland + 3 more

Conditions: Aging, Insulin Sensitivity, Chronic Disease, Mitochondria, Insulin Resistance
Interventions: Metformin, Placebo oral tablet; Drug
Lead sponsor: Oklahoma Medical Research Foundation; Other
Eligibility: 40 Years to 75 Years
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma • Madison, Wisconsin

Conditions: Pancreatic Adenocarcinoma Non-resectable
Interventions: PEGylated Recombinant Human Hyaluronidase (PEGPH20), Gemcitabine, Radiation; Drug · Radiation
Lead sponsor: Scripps Health; Other
Eligibility: Up to 90 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Mild Autonomous Cortisol Secretion (MACS), Autonomous Cortisol Secretion (ACS), Subclinical Cushing's, Mild Autonomous Cortisol Excess
Interventions: Intervention 1: Adrenalectomy, Intervention 2: Semaglutide; Procedure · Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Time Restricted Eating, Obstructive Sleep Apnea
Interventions: Time restricted eating; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 70 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Breastfeeding
Interventions: Behavior Lifestyle Intervention, Usual prenatal care; Behavioral · Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 3
States / cities: Kansas City, Kansas • Kansas City, Missouri • Liberty, Missouri

Conditions: Continuity of Patient Care, High Utilizers of Hospital Care, Patient-Centered Care
Interventions: CHAMP; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Quality of Life, IVF, Patient Satisfaction, Patient Engagement, Patient Empowerment
Interventions: CALM IVF, Standard of Care; Behavioral · Other
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 99 Years
Enrollment: 117 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Ovarian Neoplasms, Ovarian Epithelial Carcinoma, Fallopian Tube Neoplasms, High Grade Ovarian Serous Adenocarcinoma, Stage I Ovarian Cancer, Stage II Ovarian Cancer, Stage III Ovarian Cancer AJCC v8, Stage IIIA Ovarian Cancer AJCC v8, Stage IIIA1 Ovarian Cancer AJCC v8, Stage IIIA2 Ovarian Cancer AJCC v8, Stage IIIB Ovarian Cancer AJCC v8, Stage IIIC Ovarian Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IVA Ovarian Cancer AJCC v8, Stage IVB Ovarian Cancer AJCC v8
Interventions: Uterine lavage, or a wash of the womb, Blood sample, Pap smear; Diagnostic Test
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 30 Years and older · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 6
States / cities: Little Rock, Arkansas • San Francisco, California • Annapolis, Maryland + 3 more

Conditions: Critical Illness
Interventions: Early Integration of Specialty Palliative Care with Critical Care; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 60 Years and older
Enrollment: 1,091 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Periprosthetic Joint Infections
Interventions: EP Granules with Tobramycin, empty voids; Device
Lead sponsor: Elute, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 204 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 16
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Skokie, Illinois + 12 more

Conditions: Diabetes Mellitus, Type 2, Medication Adherence
Interventions: UMS Strategy, SMS Text Messaging; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 21 Years and older
Enrollment: 767 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 2
States / cities: Chicago, Illinois • New York, New York

Conditions: Female Tubal Sterilization
Interventions: Expedited Scheduling, Standard Scheduling; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 63 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Metastatic Renal Cell Carcinoma, Brain Metastases
Interventions: Cabozantinib, Nivolumab, Stereotactic Radiosurgery (SRS); Drug · Device · Radiation
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: HER2-negative Breast Cancer, Hormone-receptor-positive Breast Cancer, Metastatic Breast Cancer, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, HER2 Negative Breast Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma
Interventions: Biospecimen Collection; Procedure
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Resident Knowledge and Attitudes Regarding Cross-cultural Care, Interpersonal and Communication Skills in Patient-clinician Encounters, Patient-reported Satisfaction With Resident Physicians Involved in Their Care, Patients' Clinical Health Outcomes After Surgery
Interventions: PACTS curriculum, Standard Residency Curriculum; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 2,901 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 8
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Boston, Massachusetts + 3 more

Search by objective public record fields.

Caring Letters for Military Suicide Prevention

Gastrointestinal Implications of Voriconazole Exposure

Study of Zoledronic Acid Versus Observation on Bone Mineral Density and Incidence of Micrometastasis in Women Undergoing Pelvic Radiation for Cervical Cancer

Double-Blind Placebo-Controlled CIN Trial

Steroids and Cross-linking for Ulcer Treatment

Mucosal Impedance in Pediatric Population

Biology and Benefits of Music Play and Stories for Kids/Parents During ALL Treatment

Streamlining Telehealth for Expanded PrEP Utilization Through Community Partnerships

Intervention to Retain HIV-positive Patients in Medical Care

Antecedent Metabolic Health and Metformin Aging Study

PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer

IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion

Time Restricted Eating in Sleep Apnea

The LATCHING Pilot Project

Understanding Perspectives of Frequently-Admitted Hospital Patients

CALM IVF (Creating Affiliations, Learning, and Mindfulness for In Vitro Fertilization Patients)

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Integrated Supportive and Palliative Care for Older Adults in the ICU

Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth in/Near Infected Bone Cavities

Regimen Education and Messaging in Diabetes (REMinD)

Expedited Interval Tubal Scheduling

A Study of Cabozantinib and Nivolumab With Radiation Therapy for People With Renal Cell Carcinoma That Has Spread to the Brain

DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients

The Provider Awareness and Cultural Dexterity Toolkit for Surgeons Trial